Share on LinkedInShare on LinkedIn

ARTICLE · 16 NOVEMBER 2021

PTAB Lifts Arthrex Remand Stay

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

On October 26, 2021, Chief Administrative Patent Judge ("APJ") Boalick lifted a May 1, 2020 stay issued by the PTAB pending the Supreme Court's consideration of Arthrex in which 103 cases were placed in...

United StatesIntellectual Property

Co-authored by Evan Jones*

On October 26, 2021, Chief Administrative Patent Judge ("APJ") Boalick lifted a May 1, 2020 stay issued by the PTAB pending the Supreme Court's consideration of Arthrex in which 103 cases were placed in "administrative abeyance." The PTAB's initial stay order, which was also issued by Chief APJ Boalick, was in response to the Federal Circuit's October 31, 2019 Arthrex ruling. See Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019). In Arthrex, the Federal Circuit found that the PTO Director's inability to remove APJs at will ran afoul of the Appointments Clause, and the court remedied this by severing the APJs' employment protection from Title 5. Id. at 1338. In holding that the appointment of APJs violated the Appointments Clause, the Federal Circuit opened the door to the vacatur and remand of over a hundred PTAB decisions that had Final Written Decisions issued pre-Arthrex, which were now susceptible to Appointments

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from